Mutation in the PCSK9 gene in Omani Arab subjects with autosomal dominant hypercholesterolemia and its effect on PCSK9 protein structure
Oman Medical Journal. 2013; 28 (1): 48-52
en Inglés
| IMEMR
| ID: emr-146731
ABSTRACT
Proprotein convertase subtilisin/kexin type [PCSK9] is a crucial protein in LDL cholesterol [LDL-C] metabolism by virtue of its pivotal role in the degradation of the LDL receptor. Mutations in the PCSK9 gene have previously been found to segregate with autosomal dominant familial hypercholesterolemia [ADFH]. In this study, DNA sequencing of the 12 exons of the PCSK9 gene has been performed for two patients with a clinical diagnosis of familial hypercholesterolemia where mutation in the LDL-receptor gene hasn't been excluded. One missense mutation was detected in the exon 9 PCSK9 gene in the two ADFH patients. The patients were found to be heterozygote for Ile474Val [SNP rs562556] Using an array of in silico tools, we have investigated the effect of the above mutation on different structural levels of the PCSK9 protein Although, the mutation has already been reported in the literature for other populations, to the best of our knowledge this is the first report of a mutation in the PCSK9 gene from the Arab population, including the Omani population
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Trastornos de los Cromosomas
/
Proproteína Convertasa 2
/
Genes Dominantes
/
Hipercolesterolemia
/
LDL-Colesterol
/
Mutación
Tipo de estudio:
Informe de Casos
Límite:
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Oman Med. J.
Año:
2013
Similares
MEDLINE
...
LILACS
LIS